The Matrix Stiffness Coordinates the Cell Proliferation and PD-L1 Expression via YAP in Lung Adenocarcinoma

被引:10
|
作者
Park, Yeonhee [1 ]
Lee, Dahye [2 ]
Lee, Jeong Eun [2 ]
Park, Hee Sun [2 ]
Jung, Sung Soo [2 ]
Park, Dongil [2 ]
Kang, Da Hyun [2 ]
Lee, Song-, I [2 ]
Woo, Seong-Dae [2 ]
Chung, Chaeuk [2 ]
机构
[1] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Internal Med,Div Pulm & Crit Care Med, Seoul 34943, South Korea
[2] Chungnam Natl Univ, Coll Med, Dept Internal Med, Div Pulmonol & Crit Care Med, Daejeon 34134, South Korea
基金
新加坡国家研究基金会;
关键词
lung adenocarcinoma; matrix stiffness; PD-L1; YAP; HIPPO PATHWAY; TUMOR MICROENVIRONMENT; EXTRACELLULAR-MATRIX; EGFR-TKI; CANCER; METASTASIS; YAP/TAZ;
D O I
10.3390/cancers16030598
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Tumor development is often accompanied by abnormal extracellular matrix (ECM) remodeling and increased stiffness. A stiff ECM promotes mechanotransduction, and the predominant transcription factors implicated in this phenomenon are YAP/TAZ, beta-catenin, and NF-kappa B. We sought to investigate whether YAP acts as a critical mediator between matrix stiffness and PD-L1 in lung adenocarcinoma. We confirmed that YAP, PD-L1, and Ki-67, a marker of cell proliferation, increased as the matrix stiffness increased in vitro. Through YAP knockdown and overexpression in a stiff-matrix environment, we discovered that YAP expression levels have an impact on the expression of PD-L1 and Ki-67. This study highlights the critical role of YAP in linking the ECM to PD-L1.Abstract The extracellular matrix (ECM) exerts physiological activity, facilitates cell-to-cell communication, promotes cell proliferation and metastasis, and provides mechanical support for tumor cells. The development of solid tumors is often associated with increased stiffness. A stiff ECM promotes mechanotransduction, and the predominant transcription factors implicated in this phenomenon are YAP/TAZ, beta-catenin, and NF-kappa B. In this study, we aimed to investigate whether YAP is a critical mediator linking matrix stiffness and PD-L1 in lung adenocarcinoma. We confirmed that YAP, PD-L1, and Ki-67, a marker of cell proliferation, increase as the matrix stiffness increases in vitro using the lung adenocarcinoma cell lines PC9 and HCC827 cells. The knockdown of YAP decreased the expression of PD-L1 and Ki-67, and conversely, the overexpression of YAP increased the expression of PD-L1 and K-67 in a stiff-matrix environment (20.0 kPa). Additionally, lung cancer cells were cultured in a 3D environment, which provides a more physiologically relevant setting, and compared to the results obtained from 2D culture. Similar to the findings in 2D culture, it was confirmed that YAP influenced the expression of PD-L1 and K-67 in the 3D culture experiment. Our results suggest that matrix stiffness controls PD-L1 expression via YAP activation, ultimately contributing to cell proliferation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Regulation of PD-L1 expression by matrix stiffness in lung cancer cells
    Miyazawa, Ayako
    Ito, Satoru
    Asano, Shuichi
    Tanaka, Ichidai
    Sato, Mitsuo
    Kondo, Masashi
    Hasegawa, Yoshinori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (03) : 2344 - 2349
  • [2] PD-L1 EXPRESSION IN SUBTYPES OF ADENOCARCINOMA OF THE LUNG
    Son, Choonhee
    CHEST, 2019, 156 (04) : 307A - 307A
  • [3] Mechanobiology of Lung Cancer Cells: Regulation of PD-L1 Expression by Matrix Stiffness
    Miyazawa, A.
    Ito, S.
    Asano, S.
    Tanaka, I.
    Sato, M.
    Kondo, M.
    Hasegawa, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S518 - S518
  • [4] PD-L1 expression in squamous-cell carcinoma and adenocarcinoma of the lung
    Janzic, Urska
    Kern, Izidor
    Janzic, Andrej
    Cavka, Luka
    Cufer, Tanja
    RADIOLOGY AND ONCOLOGY, 2017, 51 (03) : 357 - 362
  • [5] Clinicopathological Characteristics of PD-L1 Expression in Lung Adenocarcinoma
    Wu, Shafei
    Shi, Xiaohua
    Sun, Jian
    Liu, Yuanyuan
    Liang, Zhiyong
    Zeng, Xuan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S816 - S816
  • [6] Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
    Yeo, Min-Kyung
    Choi, Song-Yi
    Seong, In-Ock
    Suh, Kwang-Sun
    Kim, Jin Man
    Kim, Kyung-Hee
    HUMAN PATHOLOGY, 2017, 68 : 103 - 111
  • [7] PD-L1 Expression in Lymphovascular Tumor Emboli in Lung Adenocarcinoma
    Yeh, Y.
    Ma, H.
    Ho, H.
    Chou, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S446 - S446
  • [8] Tumor Necrosis Correlates with PD-L1 and PD-1 Expression in Lung Adenocarcinoma
    Moldvay, J.
    Teglasi, V.
    Pipek, O.
    Rojko, L.
    Glasz, T.
    Vagvolgyi, A.
    Kovalszky, I.
    Gyulai, M.
    Lohinai, Z.
    Raso, E.
    Timar, J.
    Dome, B.
    Szallasi, Z.
    Reiniger, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S505 - S505
  • [9] Expression of PD-1/PD-L1 in lung adenocarcinoma and its clinical significance
    Jian Li
    Yimin Chen
    Oncology and Translational Medicine, 2021, 7 (01) : 15 - 19
  • [10] Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma
    Reiniger, Lilla
    Teglasi, Vanda
    Pipek, Orsolya
    Rojko, Livia
    Glasz, Tibor
    Vagvoelgyi, Attila
    Kovalszky, Ilona
    Gyulai, Marton
    Lohinai, Zoltan
    Raso, Erzsebet
    Timar, Jozsef
    Dome, Balazs
    Szallasi, Zoltan
    Moldvay, Judit
    ACTA ONCOLOGICA, 2019, 58 (08) : 1087 - 1094